$Histogenics(HSGX)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-02-14 AccNo: 0000315066-17-001714 Size: 9 KB 网页链接
$Histogenics(HSGX)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2017-02-02 AccNo: 0001104659-17-006058 Size: 99 KB 网页链接
$Histogenics(HSGX)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-01-12 AccNo: 0001535610-17-000066 Size: 15 KB 网页链接
$Histogenics(HSGX)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2016-12-20 AccNo: 0001535610-16-000173 Size: 15 KB 网页链接
$Histogenics(HSGX)$ 内部交易: 2016-12-15,Director,GILL DAVID N ,买入,3000普通股, $1.65
$Histogenics(HSGX)$ CORRESP [Cover] - Correspondence Filed: 2016-11-02 AccNo: 0001193125-16-757172 Size: 7 KB 网页链接
$Histogenics(HSGX)$ CORRESP [Cover] - Correspondence Filed: 2016-10-27 AccNo: 0001193125-16-748753 Size: 40 KB 网页链接
$Histogenics(HSGX)$ UPLOAD [Cover] - SEC-generated letter Filed: 2016-10-28 AccNo: 0000000000-16-098797 Size: 35 KB 网页链接
$Histogenics(HSGX)$ 8-K - Current report Filed: 2016-11-22 AccNo: 0001193125-16-775208 Size: 17 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$Histogenics(HSGX)$ 8-K - Current report Filed: 2016-11-21 AccNo: 0001193125-16-772933 Size: 13 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 网页链接